The Technical Analyst
Clarus Therapeutics [CRXT]
Exchange: NASDAQ Global Market Sector: Healthcare Industry: Drug Manufacturers - General
Clarus Therapeutics Price, Forecast, Insider, Ratings, Fundamentals & Signals
-31.16% $0.0475
/ 6 sep 2022 @ 15:59
| RATING 2022-11-08 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Sell | |
| DE: | Strong Sell | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 1/21 | 2/21 | 3/21 | 4/21 | 1/22 | 2/22 | |
| Revenue | n/a | n/a | ||||
| Gr.Profit | n/a | n/a | ||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.0170 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.0170 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0165 - 0.0785 ( +/- 65.26%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2022-06-07 | Prygocki Mark A Sr | Buy | 1 922 | Common Stock |
| 2022-06-07 | Prygocki Mark A Sr | Buy | 4 805 | Stock Option (Right to Buy) |
| 2022-06-07 | Prygocki Mark A Sr | Buy | 4 805 | Stock Option (Right to Buy) |
| 2022-06-07 | Murphy Kimberly M | Buy | 4 805 | Stock Option (Right to Buy) |
| 2022-06-07 | Amory John Kenneth | Buy | 1 922 | Common Stock |
| INSIDER POWER |
|---|
| 44.56 |
| Last 40 transactions |
| Buy: 18 969 756 | Sell: 5 390 412 |
Forecast:
01:40 - $0.0420
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.0475 (-31.16% ) |
| Volume | 2.74 mill |
| Avg. Vol. | 0 mill |
| % of Avg. Vol | 0 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CRXT
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
CRXT
Clarus Therapeutics Holdings, Inc., a pharmaceutical company, focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen therapies for inflammatory breast disease and certain forms of breast cancer; and license agreement with The Royal Institution for the Advancement of Learning/McGill University to develop and commercialize McGill's proprietary technology designed to treat conditions associated with CoQ10 deficiencies in humans. Clarus Therapeutics Holdings, Inc. was founded in 2003 and is based in Northbrook, Illinois.
Last 10 Buy Signals
Latest Press Releases
2022-04-19 09:05:00 - Press Release
Clarus Therapeutics To Present New Data For Jatenzo® (testosterone Undecanoate) At The Androgen Society 4th Annual Meeting
Jatenzo is the first fda-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions
2022-03-29 16:05:00 - Press Release
Clarus Therapeutics To Report Fourth Quarter And Full Year 2021 Financial And Operating Results
Northbrook, ill., march 29, 2022 (globe newswire) -- clarus therapeutics holdings, inc. (“clarus”) (nasdaq:crxt), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced it will release its fourth quarter and full year 2021 financial and operating results on wednesday, march 30, 2022, after the market closes.
Latest News
2022-09-06 18:41:28 - Pulse2
Clarus Therapeutics (CRXT) Stock: Why It Fell 31.16%
2022-09-02 20:22:13 - 24/7 Wall Street
These Are The Five Best And Worst Performing Penny Stocks Of 2022 (So Far)
Penny stocks are shares that usually trade at $5 or less. These stocks are mostly of small companies that usually trade over-the-counter (OTC).
2022-08-29 08:45:01 - InvestorPlace
Clarus Therapeutics (CRXT) Stock Plunges Ahead of Aug. 31 Delisting
Source: arfa adam / Shutterstock.com Clarus Therapeutics (NASDAQ: CRXT ) stock is falling hard on Monday as investors prepare for the stock to be delisted later this week. Shares of CRXT stock will no longer trade on the Nasdaq Exchange on Aug. 31, which is this Wednesday.
2022-08-25 11:51:12 - PennyStocks
Top Penny Stocks To Buy? 4 For Your Watch List Before Next Week
2022-07-30 11:30:00 - PennyStocks
Top Tricks for Trading Penny Stocks Right Now, 3 Tips
Check these tips out for your penny stocks buy list right now The post Top Tricks for Trading Penny Stocks Right Now, 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-07-05 17:13:19 - PennyStocks
Hot Penny Stocks to Buy This Week? 3 to Watch Right Now
Are these penny stocks worth buying right now? The post Hot Penny Stocks to Buy This Week?
2022-06-22 19:52:59 - PennyStocks
Hot Penny Stocks to Buy in July? Check These 3 Out
2022-05-16 19:19:09 - Seeking Alpha
Clarus Therapeutics Holdings, Inc. (CRXT) CEO Bob Dudley on Q1 2022 Results - Earnings Call Transcript
Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT ) Q1 2022 Earnings Conference Call May 16, 2022 5:15 PM ET Company Participants Bob Dudley - Founder, President and CEO Ric Peterson - CFO Frank Jaeger - Chief Commercial Officer Conference Call Participants Operator Thank you for joining in the Clarus First Quarter 2022 Financial and Operating Results Conference Call. Today's call is being recorded and webcast live on the company's website at www.clarustherapeutics.com in the Investor Relations section, and it will be available for replay for 10 days following this live call.
2022-05-04 15:17:52 - PennyStocks
Hot Penny Stocks You Need to Know About This Month
Are these penny stocks on your watchlist right now? The post Hot Penny Stocks You Need to Know About This Month appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-05-03 14:48:34 - PennyStocks
Hot Penny Stocks To Buy For Under $1 This Week
Hot penny stocks under $1 to watch this week. The post Hot Penny Stocks To Buy For Under $1 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.